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R
enal transplantation is so self-evidently 
a highly successful form of treatment 
that saves lives, improves quality of life, 
and is cost-eff ective that the limitations 
imposed by the shortage of deceased donors is 
frustrating beyond belief. To some extent these 
frustrations are mitigated by the ‘safety valve’ of 
living donation. Norway has traditionally had 
one of the most active live-donor transplanta-
tion programs, but the United Kingdom is now 
rapidly approaching the position of the United 
States, where the number of living donors 
matches or exceeds the number of heart-beating 
deceased donors. Spain, with its exceptionally 
high deceased-donor rate, is probably the only 
country where the supply of kidneys approxi-
mates the need without reliance on living-donor 
transplants. Th e UK’s record on deceased dona-
tion compares unfavorably with other countries. 
In 2005 the donor rate was 12.8 per million popu-
lation; this fi gure has been maintained in recent 
years only by an increase in donors aft er cardiac 
death that has compensated for the fall in heart-
beating donors.
One of the obstacles that has blighted discus-
sions on the best way to improve donation rates 
has been the lack of reliable information to inform 
policy. In the UK this has been a key area of focus 
in recent years with the establishment of a com-
prehensive and ongoing audit of all patients who 
die in intensive care units. Th e results of the fi rst 
three years of this Potential Donor Audit (approxi-
mately 70 000 deaths) are currently being ana-
lyzed, but they are in line with the two-year data 
published recently.1 Th e hierarchical structure 
of the Potential Donor Audit identifi es all stages 
of the heart-beating donation pathway, and the 
fi ndings are revealing. A surprisingly large pro-
portion (30%) of patients who are comatose and 
ventilated and have fi xed dilated pupils do not 
have formal tests of the brain stem. Clearly not all 
these patients — had they been tested — would 
have met the criteria for death by brain stem test-
ing, and further detailed information is required. 
Of those patients certifi ed dead aft er brain stem 
tests, there was evidence that donation was con-
sidered in 90% of cases, and the relatives were 
approached for consent for donation in 85% of the 
total. Importantly, the relatives of 41% of poten-
tial donors refused consent. Th is fi gure includes 
a small number of instances when the relatives 
stated that they knew the potential donor had 
himself or herself expressed an objection. On the 
other hand, other UK Transplant data show that 
when the potential donor had, in life, registered 
his or her wish to donate through the National 
Health Service Organ Donor Register (ODR), the 
donor’s surviving relatives overrode these wishes 
on 10% of occasions. Another way of interpret-
ing the Potential Donor Audit data is that if every 
single potential donor’s relatives were to agree 
to donation, the rate would still only reach 23.2 
per million population, compared with Spain’s 
actual donor rate of 34.6 per million.2 It should 
be noted that Spain, in addition to its excellent 
(doctor-based) coordinator network, also has a 
very much higher road-accident mortality rate 
and much greater intensive care bed availability 
than the UK, and this serves to emphasize that 
measurement of donor rates per million popula-
tion should be accompanied by a concept that is 
now gaining acceptance: the conversion rate — 
the proportion of potential donors that become 
actual donors.3
Th e merits or otherwise of the various dona-
tion laws in diff erent countries are hotly debated, 
although Matesanz (one of the prime architects 
of the Spanish system) does not believe that the 
Spanish success can be attributed to legislative 
changes,4 and there is increasing evidence to sup-
port his view.5 In the UK, two new acts came into 
force on 1 September 2006 — the Human Tissue 
Act 2004 (covering England, Wales, and Northern 
Ireland) and the Scottish equivalent, the Human 
Tissue (Scotland) Act 2006. Both acts put active 
consent (England, Wales, and Northern Ireland) or 
authorization (Scotland) at their heart. In practice, 
although the terms used are diff erent, the implica-
tions of the two acts are almost identical. In prin-
ciple, they state that if the wishes of an individual 
concerning organ donation are known, they are 
paramount and cannot — by law — be overrid-
den by relatives. Individuals can make their wishes 
known in a number of ways, of which the ODR 
is perhaps the most relevant. Registration on the 
ODR now constitutes legal consent/authorization 
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for donation, and, importantly, this applies retro-
spectively to the 13.6 million people registered on 
the ODR before the acts’ coming into force. Th is 
is an important change to the legal status of the 
ODR, and there has been extensive publicity to 
inform the public. Th e new acts have in general 
been received favorably by the public, despite the 
occasional adverse headline of the ‘Relatives lose 
right to veto organ donation’ type rather than the 
‘Individuals’ wishes to be respected’ type — a fas-
cinating example of the ability of the media to look 
at the same factual news story and report it in two 
diametrically opposed ways. Th e anxieties are also 
misplaced. In practice, organ donation is impos-
sible without the cooperation of the donor’s rela-
tives, if only because of the need for information to 
ensure quality and safety, and I do not believe that 
any transplant surgeon in the UK — or indeed in 
any other country with an ethical donation pro-
gram — would proceed with organ removal in the 
face of overwhelming hostility from the donor’s 
relatives.
If the potential donor’s wishes have not been 
made clear in life, the two acts set out very expli-
citly the appropriate member of the donor’s fam-
ily who is entitled to agree to donation on his or 
her behalf. Th e acts also regulate all aspects of 
living donation, make paired and altruistic non-
directed donation lawful, and, in addition, allow 
in situ cold perfusion of organs aft er cardiac death 
without consent/authorization if the wishes of the 
individual are not known, until such time as rela-
tives are available to give — or refuse — permis-
sion for organ donation.
Media coverage of the introduction of the acts 
was extensive and generally favorable, and it is to 
be hoped that this — together with the (unpub-
lished) UK Transplant fi nding that 90% of the 
UK population are themselves in favor of organ 
donation in principle — will go some way toward 
reducing the 41% of transplantable organs that 
are currently wasted as a result of the high rate of 
relatives’ refusal.
REFERENCES
1. Barber K, Falvey S, Hamilton C et al. Potential for organ 
donation in the United Kingdom: audit of intensive care 
records. BMJ 2006; 332: 1124–1127.
2. International figures on organ donation and transplantation. 
Council of Europe Transplant Newsletter 2005; 10: 1–44. 
3. Sheehy F, Conrad SI, Brigham LF et al. Estimating the number 
of potential organ donors in the United States. N Engl J Med 
2003; 349: 667–674.
4. Matesanz R. In: Forsythe JLR (ed). Transplantation: A 
Companion to Specialist Surgical Practice, 3rd edn. Elsevier 
Saunders: New York, 2005.
5. Rudge CJ. Organ donation and the law. Transplantation 2006 
(in the press).
